Akums Drugs and Pharmaceuticals Limited — Others, 12-08-2025: Monitoring Agency Report

Akums Drugs and Pharmaceuticals has received a monitoring agency report from CRISIL Ratings regarding its Initial Public Offer proceeds. The report confirms the company has fully deployed its net IPO funds of Rs 637.37 Cr, exactly as disclosed in the offer document, with no deviations observed. These funds were strategically utilized for repaying company and subsidiary debt, funding working capital, pursuing inorganic growth initiatives including a recent land and building acquisition, and for general corporate purposes. This transparent deployment assures investors the capital raised is effectively furthering the company's stated business objectives.